OSUR - OraSure Technologies, Inc. Stock Analysis | Stock Taper
Logo

About OraSure Technologies, Inc.

https://www.orasure.com

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions.

Carrie Eglinton Manner

CEO

Carrie Eglinton Manner

Compensation Summary
(Year 2024)

Salary $721,000
Stock Awards $4,187,301
Incentive Plan Pay $689,997
All Other Compensation $4,000
Total Compensation $5,602,298
Industry Medical - Instruments & Supplies
Sector Healthcare
Went public November 17, 1986
Method of going public IPO
Full time employees 501

Split Record

Date Type Ratio
1987-04-08 Forward 3:1

ETFs Holding This Stock

Ratings Snapshot

Rating : C+

Discounted Cash Flow 1
Return On Equity 1
Return On Assets 1
Debt To Equity 4
Price To Earnings 1
Price To Book 4
Overall Score 2

Most Recent Analyst Grades

Grade Summary

Equal Weight 1
In Line 1

Showing Top 2 of 2

Price Target

Target High $4
Target Low $4
Target Median $4
Target Consensus $4

Institutional Ownership

Summary

% Of Shares Owned 81.76%
Total Number Of Holders 218

Showing Top 3 of 218